BMS-986231

BMS-986231 Uses, Dosage, Side Effects, Food Interaction and all others data.

BMS-986231 is under investigation in clinical trial NCT02819271 (A First-in-Human Study of the Safety of Single Continuous Intravenous (IV) Infusions of CXL-1427 for up to 48 Hours in Healthy Volunteers).

Trade Name BMS-986231
Generic Cimlanod
Cimlanod Other Names BMS-986231, Cimlanod
Type
Formula C5H7NO4S
Weight Average: 177.17
Monoisotopic: 177.009578883
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
BMS-986231
BMS-986231

Innovators Monograph

You find simplified version here BMS-986231

*** Taking medicines without doctor's advice can cause long-term problems.
Share